Results

Total Results: 65 records

Showing results for "statin".
Users also searched for: statin

  1. digital.ahrq.gov/sites/default/files/docs/citation/r18hs017020-singh-final-report-2010.pdf
    January 01, 2010 - Statin SITE Total Patients Pts.
  2. digital.ahrq.gov/sites/default/files/docs/publication/r01hs015413-samore-final-report-2008.pdf
    January 01, 2008 - A total of 148 coumadin-associated potential drug-drug interactions (DDI), 43 statin-associated DDI … # of DDI per 100 person months: Range across clinics Coumadin DDI 5.5 2.3-20.0 16.3 8.7-29.5 Statin … clinics post-CCOE # of DDI per 100 person months: Range Coumadin DDI 9.9 5.1-26.5 12.9 1.7-18.6 Statin … combined: Rate ratio calculated as post CCOE/pre CCOE: Range rate ratio Coumadin DDI 1.1 0.4-11.7 Statin
  3. digital.ahrq.gov/sites/default/files/docs/citation/cds-evaluation-summary-report-p233201500023I.pdf
    March 23, 2022 - Performance Partnering Organization/ Implementation Sites Artifact Name(s) CDS Connect Pilots Statin … Use for the Primary Prevention of CVD artifact MITRE March - September 2017 AllianceChicago Statin … Part One, Screening Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part Two, Counseling Statin … Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10-Year ASCVD Risk (which was within the Statin … https://cds.ahrq.gov/cdsconnect/artifact/statin-use-primary-prevention-cvd-adults-clinician-facing-cds-intervention
  4. digital.ahrq.gov/2019-year-review/research-spotlights/improving-care-advancing-evidence-practice-through-interoperable
    January 01, 2019 - healthy-diet-and-physical-activity-cvd-prevention-adults-cardiovascular-risk 3 https://cds.ahrq.gov/cdsconnect/artifact/statin-use-primary-prevention-cvd-adults-patient-facing-cds-intervention
  5. digital.ahrq.gov/sites/default/files/docs/citation/enhancedmedhistories_102611comp.pdf
    October 01, 2011 - of annual lab monitoring for all medication groups (ACE-I/ARB, Digoxin, Diuretic, Anticonvulsant, Statin … , Fibrate, Glitazone, Nefazadone, Niacin • High CK (>500)—Statin, Fibrate • High TSH (>6)—Levothyroxine … of annual lab monitoring for all medication groups (ACE-I/ARB, Digoxin, Diuretic, Anticonvulsant, Statin … Potassium high, on ACE-I/ARB 31 1179 2.6% Creatinine high, on Metformin 16 548 2.9% CK high, on Statin … or Fibrate 7 1212 0.6% SGPT high, on Statin, Fibrate, Glitazone, Nefazadone, or Niacin 4 1254 0.3%
  6. digital.ahrq.gov/sites/default/files/docs/cds-authoring-tool-qas-020719.pdf
    December 08, 2017 - For an example, see the alternate statin use configuration. … https://cds-hooks.org/ https://github.com/AHRQ-CDS/AHRQ-CDS-Connect-CQL-SERVICES/blob/master/localHooks/statin-use.json.alternate
  7. digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
    January 01, 2017 - more than half of the alerts that would have been triggered for DDIs involving cholesterol-lowering statin … drugs were inappropriate because the dose of the statin was not considered by the software.24 More … Successful strategy to improve the specificity of electronic statin-drug interaction alerts.
  8. digital.ahrq.gov/sites/default/files/docs/publication/r21hs019726-kahn-final-report-2014.pdf
    January 01, 2014 - 39400065 sertraline 58160070 Simvastatin 39400075 SNRI 5818 duloxetine 58180025 Combination,Products,(statin
  9. digital.ahrq.gov/sites/default/files/docs/citation/r01hs022728-zhou-final-report-2018.pdf
    January 01, 2018 - Encoding and Processing Patient Allergy Information in EHRs - Final Report AHRQ Grant Final Progress Report Title of Project: Encoding and Processing Patient Allergy Information in EHRs Principle Inve…
  10. digital.ahrq.gov/sites/default/files/docs/citation/r21hs025005-snyder-final-report-2019.pdf
    January 01, 2019 - Targeted by Alert (number of alerts evaluated) Indication 5 Need for ACE/ARBb therapy (2) Need for statin … 5 Drug-drug interaction to reduce plasma concentration of immunosuppressant drug (1) Sub-optimal statin … anti-diabetic) non-adherence (6) Cost 2 Cost-savings opportunity through switch to alternative drug (statin
  11. digital.ahrq.gov/sites/default/files/docs/citation/EnhancedMedHistoriesImplementationGuide.pdf
    November 01, 2011 - for liver enzyme elevation) • NSAID (Nonsteroidal Anti-inflammatory Drug) • Potassium Supplement • Statin … < 0.3 TSH > 6 K Supplement Potassium > 5.5 Metformin Creatinine > 1.4 NSAID Creatinine > 2.0 Statin … Levothyroxine TSH: none found in past 12 months Anticonvulsant Serum drug level: none found in past 12 months Statin
  12. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017037-ornstein-final-report-2010.pdf
    January 01, 2010 - • Avoidance of itraconazole and statin. 6 • Avoidance of lithium and thiazide.
  13. digital.ahrq.gov/sites/default/files/docs/medication-management-elderly-transcript-081811.pdf
    June 16, 2021 - So if you have diabetes, often patients would be on a statin, ACE-inhibitor-ARB, Solfunylurea, metformin … re on a drug or if you weren’t because we wanted patients to - so maybe they stopped taking their statin … We wanted to give them a different message than if they were taking their statin.
  14. digital.ahrq.gov/sites/default/files/docs/publication/r21hs021581-goodney-final-report-2015.pdf
    January 01, 2015 - congestive heart failure, COPD, smoking, renal failure, contralateral carotid stenosis, and absence of statin
  15. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017018-lehmann-final-report-2010.pdf
    January 01, 2010 - Medication Monitoring for Vulnerable Populations via IT Grant Final Report Grant ID: R18HS17018-02 Medication Monitoring for Vulnerable Populations via IT Inclusive Dates: 09/21/07 – 05/31/10 Principal Investigator: Dr. Christoph Ulrich Lehmann Team Members: Sean Berenholtz * David …
  16. digital.ahrq.gov/sites/default/files/docs/publication/r18hs018226-sequist-final-report-2013.pdf
    January 01, 2013 - A Risk-Based Approach to Improving Management of Chronic Kidney Disease - Final Report Grant Final Report Grant ID: R18HS018226 A Risk-Based Approach to Improving Management of Chronic Kidney Disease Inclusive Project Dates: 09/30/09 – 07/31/13 Principal Investigator: Thomas D. Sequist MD, MPH Team Membe…
  17. digital.ahrq.gov/sites/default/files/docs/resource/B7_Archives_Pohl_HS17034_1013_1.pdf
    February 14, 2011 - Data Analysis Protocol (Preliminary Draft) 1 “A Partnership for Clinician EHR Use & Quality of Care” DATA ANALYSIS PROTOCOL Revision Date: February 14, 2011 DATA COLLECTED Note: All data are collected at the clinician level unless noted otherwise. I. Medication Safety A. Timepoints & Loo…
  18. digital.ahrq.gov/sites/default/files/docs/publication/r18hs017072-lobach-final-report-2011.pdf
    January 01, 2011 - rules and the requirement to activate the rules Medication Class Conditions Contributing to Rule Statin … % Arm #3 (Reports+) Adherence N=736 p All Medication Classes 41.3 41.2 0.82 42.9 0.35 Statin … % Arm #3 (Reports+) Adherence N=493 p All Medication Classes 50.5 51.3 0.61 52.7 0.35 Statin
  19. digital.ahrq.gov/sites/default/files/docs/clinical-care-slides-10142020.pdf
    October 14, 2020 - A National Web Conference on Applying Advanced Analytics in Clinical Care: Slides AHRQ National Web Conference on Applying Advanced Analytics in Clinical Care Moderated by: Chun-Ju (Janey) Hsiao, PhD Agency for Healthcare Research and Quality Presented by: Alexander Turchin, MD, MS Judit…
  20. digital.ahrq.gov/sites/default/files/docs/citation/r21hs026257-friedman-final-report-2020.pdf
    January 01, 2020 - cancer screening; Osteoporosis screening (if high risk), Sexually transmitted infections counseling; Statin … activity counseling HIV HIV Screening OST Osteoporosis screening LUN Lung cancer screening STA Statin

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: